Skip to main content
Last Updated
In the Matter of Pfizer Inc., a corporation, and Wyeth, a corporation.
FTC Matter/File Number
091 0053
Docket Number
Enforcement Type
Part 2 Consents

Case Summary

The Commission challenged Pfizer Inc.’s proposed $68 billion acquisition of Wyeth and required significant divestitures to preserve competition in multiple U.S. markets for animal pharmaceuticals and vaccines. The proposed consent order remedies the anticompetitive effects the Commission believes are likely to result from the transaction in numerous markets for animal vaccines and animal pharmaceutical products. After a thorough investigation, the Commission concluded that the transaction does not raise anticompetitive concerns in any human health product markets.